2019
DOI: 10.1016/j.msec.2019.109874
|View full text |Cite
|
Sign up to set email alerts
|

Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(11 citation statements)
references
References 36 publications
0
11
0
Order By: Relevance
“…In one study, inhibitory effects of curcumin‐loaded SLN nanoparticles with less than 200 nm in size and PDI 0.2 on breast cancer cells were reported (Fathy Abd‐Ellatef et al., 2020). Similarly, in another study, SLN nanoparticles were prepared with a PS <200 nm, and the results showed the high potential of these nanoparticles to treat breast cancer and leukemia (Üner et al., 2019). In a study conducted in 2019, quercetin was used to load SLN nanoparticles.…”
Section: Discussionmentioning
confidence: 87%
“…In one study, inhibitory effects of curcumin‐loaded SLN nanoparticles with less than 200 nm in size and PDI 0.2 on breast cancer cells were reported (Fathy Abd‐Ellatef et al., 2020). Similarly, in another study, SLN nanoparticles were prepared with a PS <200 nm, and the results showed the high potential of these nanoparticles to treat breast cancer and leukemia (Üner et al., 2019). In a study conducted in 2019, quercetin was used to load SLN nanoparticles.…”
Section: Discussionmentioning
confidence: 87%
“…This method has been used to prepare celecoxib-loaded SLNs using Precirol ® ATO 5 (glyceryl palmitostearate) as lipid and Cremophor ® EL (polyoxyl-35 castor oil) as emulsifier. These SLNs, with a PS of <200 nm and sustained drug delivery, were suggested to have potential for the treatment of breast cancer and leukemia [ 53 ]. Recently, atorvastatin-loaded SLNs were produced by HPH using Compritol ® 888 ATO (glyceryl behenate) as solid lipid and poloxamer 188-Phospholipon 90H as emulsifier.…”
Section: Methods For Slns and Nlcs Preparationmentioning
confidence: 99%
“…Nanocarriers, such as nanostructured lipid carriers (NLC), have proven to be potential candidates to work as non-viral genetic vehicles due to important features such as increased chemical stability, higher loading capacity of nucleic acids, lower cytotoxicity and controlled release ( 186 ). Another strategy used in the design of safer and more efficient genetic vehicles is the construction of dual ligand-decorated lipid carriers.…”
Section: Most Common Cancers Treated With Gene Therapy: the Potentialmentioning
confidence: 99%